Clinical Trials Browser

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

NCT03983057 2026-02-11

Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

Phase 2 Completed

392 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03365882 2026-02-10

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Phase 2 Completed

240 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00556413 2026-02-05

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Phase 2 Completed

42 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01715441 2026-02-05

NEXIRI2

Phase 2 Completed

173 enrolled

Gastrointestinal

Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

NCT05176223 2026-02-05

68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

Phase 2 Completed

29 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT03727880 2026-02-04

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Phase 2 Completed

28 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03264404 2026-01-27

Azacitidine and Pembrolizumab in Pancreatic Cancer

Phase 2 Completed

36 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT04524702 2026-01-23

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Phase 2 Completed

10 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT05166239 2026-01-23

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Phase 2 Completed

66 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT05641896 2026-01-22

18F-FAPI-74 GI

Phase 2 Completed

109 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT04505553 2026-01-21

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

Phase 2 Completed

78 enrolled 14 charts

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT05512377 2026-01-21

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Phase 2 Completed

99 enrolled

GastrointestinalGenitourinaryThoracic

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT05254847 2026-01-20

Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC

Phase 2 Completed

65 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT05349331 2026-01-15

WATCH

Phase 2 Completed

74 enrolled

Gastrointestinal

Conversion Disorder, Carcinoma, Hepatocellular

NCT04744831 2026-01-14

DESTINY-CRC02

Phase 2 Completed

122 enrolled 21 charts 1 FDA

Gastrointestinal

Colorectal Neoplasms

NCT03366155 2026-01-08

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

Phase 2 Completed

24 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05348811 2026-01-06

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Phase 2 Completed

25 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT05628857 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor

Phase 2 Completed

29 enrolled

Gastrointestinal

Gastrointestinal Neoplasms

NCT03199274 2026-01-02

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Phase 2 Completed

104 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03443492 2025-12-30

Pancreas

Phase 2 Completed

130 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT05532319 2025-12-30

FRONT-1

Phase 2 Completed

64 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05898854 2025-12-30

[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer

Phase 2 Completed

20 enrolled

Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT07304388 2025-12-30

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Phase 2 Completed

96 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT03745794 2025-12-23

Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery

Phase 2 Completed

136 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT05024513 2025-12-18

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Phase 2 Completed

127 enrolled

Gastrointestinal

Klatskin Tumor

NCT03910387 2025-12-16

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

Phase 2 Completed

23 enrolled 15 charts

Gastrointestinal

Pancreatic Neoplasms

NCT05001347 2025-12-16

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

Phase 2 Completed

25 enrolled 11 charts

BreastGastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

PROTECT

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

METCAP

CKNO-HEP

Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Palbociclib and Cetuximab in Metastatic Colorectal Cancer

Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

CAIRE

DREAM

A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC)

ARETHUSA

TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

PASS-01

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)

Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Participants With Colorectal Cancer

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

NEXIRI2

68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Azacitidine and Pembrolizumab in Pancreatic Cancer

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

18F-FAPI-74 GI

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC

WATCH

DESTINY-CRC02

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Pancreas

FRONT-1

[68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery

Biliary Drainage Plus HAIC in Locally Advanced pCCA

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors